IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (18)
Evercore
UnderWriters* | |||||||||||
Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 11 | Vaxxinity Inc. | Health-Care | 13 | 6 | BAML | JEFF | EVCR | 62.6% | 27.3% | ||
Oct 29 | Aura Bioscience | Health-Care | 14 | 5 | COWN | SVB | EVCR | 29.1% | 5.7% | ||
Oct 20 | Ventyx Bioscien | Health-Care | 16 | 9 | JEFF | EVCR | PPRJ | 17.9% | 31.4% | ||
Oct 15 | MiNK Therapeuti | Health-Care | 12 | 3 | EVCR | WB | 21.5% | 0% | |||
Oct 8 | IsoPlexis Corp. | Health-Care | 15 | 8 | MS | COWN | EVCR | 47% | -23.2% | ||
Sep 15 | DICE Therapeuti | Health-Care | 17 | 12 | BAML | SVB | EVCR | 12.2% | 117% | ||
Aug 10 | Eliem Therapeut | Health-Care | 12.5 | 6 | SVB | EVCR | Stifel | 23.8% | 27.2% | ||
Jul 29 | Rallybio Corp. | Health-Care | 13 | 6 | JEFF | COWN | EVCR | 10.8% | 8.5% | ||
Jul 29 | Icosavax Inc. | Health-Care | 15 | 12 | JEFF | COWN | EVCR | 25.9% | 133.1% | ||
Jun 30 | Integral Ad Sci | Technology | 18 | 15 | MS | JEFF | EVCR | 56.1% | 14.3% | ||
Jun 30 | Aerovate Therap | Health-Care | 14 | 8 | JEFF | COWN | EVCR | 13% | 63.1% | ||
Jun 11 | Janux Therapeut | Health-Care | 17 | 11 | BAML | COWN | EVCR | 20.9% | 47.9% | ||
May 14 | Vera Therapeuti | Health-Care | 11 | 4 | JEFF | COWN | EVCR | 14.8% | 4.5% | ||
May 7 | Talaris Therape | Health-Care | 17 | 8 | MS | SVB | EVCR | 33.4% | -4.4% | ||
Apr 30 | Werewolf Therap | Health-Care | 16 | 7 | JEFF | SVB | EVCR | 45.8% | 0.6% | ||
Mar 19 | Finch Therapeut | Health-Care | 17 | 7 | BAML | JEFF | EVCR | 28.1% | 25.4% | ||
Feb 5 | Vor Biopharma I | Health-Care | 18 | 9 | GS | EVCR | BRCL | 33.9% | 108.3% | ||
Jan 8 | Cullinan Oncolo | Health-Care | 29.9 | 21 | MS | LRNK | EVCR | 19.3% | 0% |
*
Lead manager or one of top three managers in an underwriting team.